Journal of Neurology

, Volume 215, Issue 1, pp 1–26 | Cite as

Geography in multiple sclerosis

  • John F. Kurtzke
Original Investigations

Summary

Both mortality and morbidity data indicate quite clearly that multiple sclerosis is a geographically-related disease, and thus MS can be thought of as an acquired environmental (exogenous) illness. High frequency parts of the world for MS are Europe between 65° and 45° north latitude, northern United States and southern Canada, New Zealand, and southern Australia. These regions are bounded by medium frequency MS regions: in Europe to the north, east, and south; in America for southern U.S.; and the remainder of Australia. Latin America, Asia and Africa are essentially of low frequency from present data. Latitude is not a sufficient criterion: at 40° north latitude, MS is high in America, medium in Europe, and low in Asia.

All high and medium risk areas therefore are in Europe or European colonies; thus MS is the white man's burden spread from western Europe. Within the U.S., MS is less common among Negroes, Japanese, and possibly Amerindians than in whites regardless of geography. Migration studies among risk areas indicate that migrants keep much of the risk of their birthplace, but also that overall the risk is decreased by high-to-low migration, and probably increased by low-to-high. For the former, it seems that adolescence is the age critical for retention of birthplace risk. Some preliminary data on a possible epidemic of MS are also presented.

All the epidemiologic information would be most easily explained if MS were an infectious (?viral) illness with prolonged latency. The proof of this though must come from the laboratory.

Key words

Multiple sclerosis Geographic distribution Race Migration Clustering 

Zusammenfassung

Die Daten über Mortalität und Vorkommen der Multiplen Sklerose zeigen eindeutig, daß es sich um eine Krankheit mit einer bestimmten geographischen Verbreitung handelt, und daß die Multiple Sklerose als eine erworbene, (exogene) umweltbedingte Krankheit angesehen werden muß. Gebiete mit hoher Frequenz der Multiplen Sklerose liegen in Europa zwischen dem 65. und 45. Breitengrad, in den nördlichen Vereinigten Staaten, Südkanada, Neuseeland und Südaustralien. An diese Regionen grenzen solche mit einer mittleren MS-Frequenz, in Europa nördlich, östlich und südlich, in Amerika gilt das für die südlichen Vereinigten Staaten und es gilt für den Rest von Australien. Lateinamerika, Asien und Afrika zeigen im wesentlichen nach den heutigen Untersuchungen eine niedrige Frequenz. Aber der Breitengrad ist nicht genug: auf dem 40. Breitengrad nördlich ist die Multiple Sklerose in Amerika sehr häufig, mittelhäufig in Europa und niedrig in Asien.

Alle Gebiete hohen und mittleren Risikos liegen deswegen in Europa oder in den europäischen Kolonien. Die Multiple Sklerose ist also die Bürde des weißen Mannes, die sich von Westeuropa aus ausgebreitet hat. Innerhalb der Vereinigten Staaten ist Multiple Sklerose seltener bei den Negern und Japanern und wahrscheinlich auch bei den amerikanischen Indianern als bei den Weißen, unabhängig von der Geographie. Untersuchungen des Einflusses der Wanderung von Risikogegenden aus zeigen, daß die Wanderer das Risiko ihrer Geburtsländer mit sich bringen, daß aber im großen und ganzen das Risiko abnimmt, wenn die Wanderung von risikoreichen zu risikoniedrigen Gebieten erfolgt ist, und daß das Risiko zunimmt, wenn die Wanderung in umgekehrter Richtung erfolgt. Bei der ersteren scheint es, daß die Adoleszenz das kritische Alter für die Beibehaltung des Risikos des Geburtslandes darstellt. Es werden vorläufige Daten einer möglichen MS-Epidemie vorgestellt. Alle epidemiologischen Unterlagen werden am leichtesten erklärbar, wenn die Multiple Sklerose eine infektiöse (Virus?) Krankheit mit langer Latenz wäre. Der Nachweis dafür muß allerdings durch Laboratoriumsuntersuchungen erbracht werden.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Acheson, E. D.: The epidemiology of multiple sclerosis. In: D. McAlpine, C. E. Lumsden, E. D. Acheson, Multiple Sclerosis. A Reappraisal. Second Edition, pp. 3–80. Baltimore: Williams and Wilkins 1972Google Scholar
  2. Beebe, G. W., Kurtzke, J. F., Kurland, L. T., Auth, T. L., Nagler, B.: Studies on the natural history of multiple sclerosis. 3. Epidemiologic analysis of the Army experience in World War II. Neurology (Minneap.) 17, (1967)Google Scholar
  3. Dassel, H.: Discussion on the epidemiology of MS. In: E. J. Field, T. M. Bell, and P. R. Carnegie (eds.), Multiple Sclerosis. Progress in Research, pp. 241–242. Amsterdam: North-Holland 1972Google Scholar
  4. Dean, G: Annual incidence, prevalence, and mortality of multiple sclerosis in white South-African-born and in white immigrants to South Africa. Brit. Med. J. 1967 II, 724–730Google Scholar
  5. Dean, G., Kurtzke, J. F.: On the risk of multiple sclerosis according to age at immigration to South Africa. Brit. Med. J. 1971 III, 725–729Google Scholar
  6. Dean, G., McLoughlin, H., Brady, R., Adelstein, A. M., Tallett-Williams, J.: Multiple sclerosis among immigrants in Greater London. Brit. Med. J. 1976 I, 861–864Google Scholar
  7. Detels, R., Brody, J. A., Edgar, A. H.: Multiple sclerosis among American Japanese and Chinese migrants to California and Washington. J. Chron. Dis. 25, 3–10 (1972)Google Scholar
  8. Detels, R., Visscher, B., Coulson, A., Malmgren, R.: Evidence for lower susceptibility to multiple sclerosis among Japanese. Neurology (Minneap.) 25, 357 (1975)Google Scholar
  9. Detels, R., Visscher, B., Malmgren, R., Dudley, J., Coulson, A. H.: Evidence of protection against multiple sclerosis. Neurology (Minneap.) 26, 357 (1976)Google Scholar
  10. Goldberg, I. D., Kurland, L. T.: Mortality in 33 countries from diseases of the nervous system. World Neurol. 3, 444–465 (1962)Google Scholar
  11. Hyllested, K.: Disseminated Sclerosis in Denmark. Prevalence and Geographical Distribution, pp. 147 + atlases. Copenhagen: J. Jørgensen 1956Google Scholar
  12. Kurland, L. T.: The epidemiologic characteristics of multiple sclerosis. In: P. J. Vinken, G. W. Bruyn (eds.), Multiple Sclerosis and Other Demyelinating Diseases, pp. 63–84. Amsterdam: North-Holland 1970Google Scholar
  13. Kurtzke, J. F.: General features of the prevalence of multiple sclerosis. J. Indian Med. Prof. 11, 4896–4901, 4895 (1964)Google Scholar
  14. Kurtzke, J. F.: On the time of onset in multiple sclerosis. Acta Neurol. Scand. 41, 140–158 (1965a)Google Scholar
  15. Kurtzke, J. F.: Medical facilities and the prevalence of multiple sclerosis. Acta Neurol. Scand. 41, 561–579 (1965b)Google Scholar
  16. Kurtzke, J. F.: An evaluation of the geographic distribution of multiple sclerosis. Acta Neurol. Scand. 42 (Suppl. 19), 91–117 (1966)Google Scholar
  17. Kurtzke, J. F.: Further considerations on the geographic distribution of multiple sclerosis. Acta Neurol. Scand. 43, 283–298 (1967a)Google Scholar
  18. Kurtzke, J. F.: On the fine structure of the distribution of multiple sclerosis. Acta Neurol. Scand. 43, 257–282 (1967b)Google Scholar
  19. Kurtzke, J. F.: A Fennoscandian focus of multiple sclerosis. Neurology (Minneap.) 18, (Part 1), 16–20 (1968)Google Scholar
  20. Kurtzke, J. F.: Some epidemiologic features compatible with an infectious origin for multiple sclerosis. Add. ad Int. Arch. Allergy 36, 59–81 (1969)Google Scholar
  21. Kurtzke, J. F.: Migration and latency in multiple sclerosis. In: E. J. Field, T. M. Bell, P. R. Carnegie (eds.), Multiple Sclerosis. Progress in Research, pp. 208–228, Amsterdam: North-Holland 1972Google Scholar
  22. Kurtzke, J. F.: Further features of the Fennoscandian focus of multiple sclerosis. Acta Neurol. Scand. 50, 478–502 (1974)Google Scholar
  23. Kurtzke, J. F.: A reassessment of the distribution of multiple sclerosis. Part One. Acta Neurol. Scand. 51, 110–136 (1975a)Google Scholar
  24. Kurtzke, J. F.: A reassessment of the distribution of multiple sclerosis. Part Two. Acta Neurol. Scand. 51, 137–157 (1975b)Google Scholar
  25. Kurtzke, J. F.: An overview of the epidemiology of multiple sclerosis. In: T. Yonezawa et al. (eds.), International Symposium on the Aetiology and Pathogenesis of the Demyelinating Diseases, Sept., 1973, Kyoto (in press (a))Google Scholar
  26. Kurtzke, J. F.: Multiple sclerosis from an epidemiologic viewpoint. In: E. J. Field (ed.), Problems in Multiple Sclerosis. (in press (b))Google Scholar
  27. Kurtzke, J. F., Beebe, G. W., Norman, J. E., Jr.: Epidemiology of multiple sclerosis in the United States: Preliminary data. Neurology (Minneap.) 25, 356–357 (1975)Google Scholar
  28. Kurtzke, J. F., Dean, G., Botha, D. P. J.: A method of estimating the age at immigration of white immigrants to South Africa, with an example of its importance. S. Afr. Med. J. 44, 663–669 (1970)Google Scholar
  29. Kurtzke, J. F., Hamtoft, H.: Multiple sclerosis and Hodgkin's disease in Denmark. Acta Neurol. Scand. 53, 358–375 (1976)Google Scholar
  30. Kurtzke, J. F., Hyllested, K.: Multiple sclerosis. An epidemic disease in the Faeroes. Trans. Am. Neurol. Assoc. 100, 213–215 (1975)Google Scholar
  31. Kurtzke, J. F., Kurland, L. T.: The epidemiology of neurologic disease. In: A. B. Baker, L. H. Baker (eds.), Clinical Neurology Volume 3, pp. 80. Hagerstown, MD: Harper and Row 1973Google Scholar
  32. Kurtzke, J. F., Kurland, L. T., Goldberg, I. D.: Mortality and migration in multiple sclerosis. Neurology (Minneap.) 21, 1186–1197 (1971)Google Scholar
  33. Leibowitz, U., Alter, M.: Multiple Sclerosis. Clues to Its Cause, pp. 373. Amsterdam: North-Holland 1973Google Scholar
  34. Schapira, L., Poskanzer, D. C., Miller, H.: Familial and conjugal multiple sclerosis. Brain 86, 315–332 (1963)Google Scholar

Copyright information

© Springer-Verlag 1977

Authors and Affiliations

  • John F. Kurtzke
    • 1
  1. 1.Departments of Neurology and of Community MedicineGeorgetwon University School of Medicine, and Neurology Service, Veterans Administration HospitalWashington, D.C.USA

Personalised recommendations